ATZORI, MARIA GRAZIA
ATZORI, MARIA GRAZIA
Dipartimento di Scienze cliniche e Medicina Traslazionale
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose
2022-07-16 Sbardella, D; Tundo, Gr; Mecchia, A; Palumbo, C; Atzori, Mg; Levati, L; Boccaccini, A; Caccuri, Am; Cascio, P; Lacal, Pm; Graziani, G; Varano, M; Coletta, M; Parravano, M
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding
2016-01-01 Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding
2016-01-01 Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth
2016-01-01 Ceci, C; Tentori, L; Atzori, Mg; Lacal, P; Bonanno, E; Scimeca, M; Cicconi, R; Mattei, M; De Martino, M; Vespasiani, G; Miano, R; Graziani, G
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research
2024-01-01 Ceci, C; Garcia-Chico, C; Atzori, Mg; Lacal, Pm; Lista, S; Santos-Lozano, A; Graziani, G; Pinto-Fraga, J
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.
2017-01-01 Ruffini, F; Levati, L; Graziani, G; Caporali, S; Atzori, M; D'Atri, S; Lacal, P
Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells.
2018-01-01 Lacal, P; Atzori, M; Ruffini, F; Tentori, L; Graziani, G
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib
2020-01-01 Atzori, Mg; Ceci, C; Ruffini, F; Trapani, M; Barbaccia, Ml; Tentori, L; D'Atri, S; Lacal, Pm; Graziani, G
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors
2023-04-29 Ruffini, F; Ceci, C; Atzori, Mg; Caporali, S; Levati, L; Bonmassar, L; Cappellini, Gca; D'Atri, S; Graziani, G; Lacal, Pm
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor
2022-11-14 Atzori, Mg; Ceci, C; Ruffini, F; Scimeca, M; Cicconi, R; Mattei, M; Lacal, Pm; Graziani, G
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
2018-01-01 Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 16-lug-2022 | A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose | Sbardella, D; Tundo, Gr; Mecchia, A; Palumbo, C; Atzori, Mg; Levati, L; Boccaccini, A; Caccuri, Am; Cascio, P; Lacal, Pm; Graziani, G; Varano, M; Coletta, M; Parravano, M | Articolo su rivista | |
| 1-gen-2016 | Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding | Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P | Intervento a convegno | |
| 1-gen-2016 | Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding | Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P | Articolo su rivista | |
| 1-gen-2016 | Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth | Ceci, C; Tentori, L; Atzori, Mg; Lacal, P; Bonanno, E; Scimeca, M; Cicconi, R; Mattei, M; De Martino, M; Vespasiani, G; Miano, R; Graziani, G | Articolo su rivista | |
| 1-gen-2024 | Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research | Ceci, C; Garcia-Chico, C; Atzori, Mg; Lacal, Pm; Lista, S; Santos-Lozano, A; Graziani, G; Pinto-Fraga, J | Articolo su rivista | |
| 1-gen-2017 | Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1. | Ruffini, F; Levati, L; Graziani, G; Caporali, S; Atzori, M; D'Atri, S; Lacal, P | Articolo su rivista | |
| 1-gen-2018 | Poly(ADP‑ribose) polymerase inhibitor olaparib hampers placental growth factor‑driven activation of myelomonocytic cells. | Lacal, P; Atzori, M; Ruffini, F; Tentori, L; Graziani, G | Articolo su rivista | |
| 1-gen-2020 | Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib | Atzori, Mg; Ceci, C; Ruffini, F; Trapani, M; Barbaccia, Ml; Tentori, L; D'Atri, S; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 29-apr-2023 | Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors | Ruffini, F; Ceci, C; Atzori, Mg; Caporali, S; Levati, L; Bonmassar, L; Cappellini, Gca; D'Atri, S; Graziani, G; Lacal, Pm | Articolo su rivista | |
| 14-nov-2022 | The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor | Atzori, Mg; Ceci, C; Ruffini, F; Scimeca, M; Cicconi, R; Mattei, M; Lacal, Pm; Graziani, G | Articolo su rivista | |
| 1-gen-2018 | The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo. | Atzori, Mg; Tentori, L; Ruffini, S; Ceci, C; Bonanno, E; Scimeca, M; Lacal, P; Graziani, G | Articolo su rivista |